AEON Biopharma Insider Trades

AEON

Track insider trading activity from AEON Biopharma executives and directors. See which insiders are buying and selling AEON stock.

Trades Last 12 Months

AEON Price

All Insider Trades for AEON Biopharma

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bencich John CHIEF FINANCIAL OFFICER
Holding Value $552k 754,717 shares
Last Trade
Apr 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$671k 754,717 shares
$0.89
$0.73
Wilson Alexander Blair Clo, Cso, And Corp Secretary
Holding Value $1.6M 2,183,005 shares
Last Trade
Mar 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.42M 1,316,872 shares
$1.08
$0.73
Oh Chad CHIEF MEDICAL OFFICER
Holding Value $1.6M 2,183,436 shares
Last Trade
Mar 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.42M 1,316,872 shares
$1.08
$0.73
Sy Jennifer PRINCIPAL ACCOUNTING OFFICER
Holding Value $1.1M 1,501,176 shares
Last Trade
Mar 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1M 925,925 shares
$1.08
$0.73
Bancroft Robert E. PRESIDENT & CEO
Holding Value $2.32M 3,177,103 shares
Last Trade
Feb 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.91M 3,000,000 shares
$0.97
$0.73
Daewoong Co., Ltd 10% owner
Holding Value $8.74M 11,951,714 shares
Last Trade
Jan 21, 2026 Sale
$26.2M 19,236,631 shares
$1.36
$0.73
Holding Value $226k 308,641 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 308,641 shares
$0.49
$0.73
Forth Marc Director
Holding Value $271k 370,370 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180k 370,370 shares
$0.49
$0.73
Thunen Shelley B Director
Holding Value $226k 308,641 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 308,641 shares
$0.49
$0.73
Fischer Jost Director
Holding Value $195k 266,785 shares
Last Trade
May 21, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$29.4k 60,000 shares
$0.49
$0.73
Carter Eric G Director
Holding Value $226k 308,641 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 308,641 shares
$0.49
$0.73
Holding Value $1.49M 2,031,773 shares
Last Trade
Aug 11, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.73B 7,380,394 shares
$505.44
$0.73
Holding Value $0 0 shares
Last Trade
Jul 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.73
Grodnensky Oleg 10% owner, Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jul 03, 2023 Sale
No data
No data
$0.73
Holding Value $1.98M 2,709,235 shares
Last Trade
Mar 23, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$0.73
Pace David 10% owner, Co-chief Executive Officer
Holding Value $5.05M 6,900,000 shares
Last Trade
Jan 07, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.73
Pforzheimer Carl Andrew 10% owner, Co-chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jan 07, 2021 Sale
No data
No data
$0.73
Golkin Gregory 10% owner, President
Holding Value $0 0 shares
Last Trade
Jan 07, 2021 Sale
No data
No data
$0.73
Holding Value $0 0 shares
Last Trade
Jan 07, 2021 Sale
No data
No data
$0.73

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up